(Q46170789)

20 December 2017

title

Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling (English)

1 reference

20 December 2017

author name string

Stefan Schäfer

1

1 reference

20 December 2017

Peter Ellinghaus

2

1 reference

20 December 2017

Wiebke Janssen

3

1 reference

20 December 2017

Frank Kramer

4

1 reference

20 December 2017

Klemens Lustig

5

1 reference

20 December 2017

Hendrik Milting

6

1 reference

20 December 2017

Raimund Kast

7

1 reference

20 December 2017

Martina Klein

8

1 reference

20 December 2017

publication date

8 January 2009

1 reference

20 December 2017

published in

Cardiovascular Research

1 reference

20 December 2017

volume

82

1 reference

20 December 2017

page(s)

30-39

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Cor pulmonale: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Evidence-based pharmacologic management of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Endothelin-1 and right-sided heart failure in rats: effects of an endothelin receptor antagonist on the failing right ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Osteopontin and cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

Osteopontin expression is required for myofibroblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

DOSE RESPONSE OF INTRAVENOUS SILDENAFIL ON SYSTEMIC AND REGIONAL HEMODYNAMICS IN HYPOXIC NEONATAL PIGLETS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP002

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP002

1 reference

20 December 2017

PubMed ID

19131365

1 reference

20 December 2017